Literature DB >> 6092479

Microplate method for retrovirus-induced transformation of normal human T-cells.

K Sugamura, M Sakitani, Y Hinuma.   

Abstract

An adult T-cell leukemia virus (ATLV) producer cell line (TL-Su) derived from a healthy ATLV-carrier, was used for virus-induced transformation of normal human T-cells. The transformation was carried out on microplates by co-cultivation of a limiting number of normal peripheral blood leukocytes (PBL) as transformed target cells and 2 X 10(4)/well of TL-Su cells irradiated lethally. The frequency of establishment of transformed cell lines correlated with the dose of PBL. The transforming target cell number was estimated to be approximately one per 500 PBL by the microplate method using TL-Su effector cells. When 1 X 10(3) PBL per well were plated, more than 90% of wells showed immortalizing transformation of PBL. Twenty transformed cell lines obtained from microplates with 500 PBL per well were shown to be of T-cell lineage. Ten of them were defined as belonging to the helper/inducer T-cell subset with Leu 3a antigen, and 4 were demonstrated to be of the cytotoxic/suppressor T-cell subset with Leu 2a antigen. The transformed cells always expressed Tac and OKT9 antigens (considered to be IL2 and transferrin receptors respectively). ATLV antigens were also expressed in all these cell lines tested, but their molecular species detected by radioimmunoprecipitation varied regardless of PBL donors and T-cell subsets. We propose this microplate transformation method as an advantageous system for obtaining abundant T-cell lines and for screening their immunological functions.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6092479     DOI: 10.1016/0022-1759(84)90413-7

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  6 in total

1.  Indicators of retention in remote digital health studies: a cross-study evaluation of 100,000 participants.

Authors:  Abhishek Pratap; Elias Chaibub Neto; Phil Snyder; Carl Stepnowsky; Noémie Elhadad; Daniel Grant; Matthew H Mohebbi; Sean Mooney; Christine Suver; John Wilbanks; Lara Mangravite; Patrick J Heagerty; Pat Areán; Larsson Omberg
Journal:  NPJ Digit Med       Date:  2020-02-17

2.  Specific immunoglobulin E responses in ZAP-70-deficient patients are mediated by Syk-dependent T-cell receptor signalling.

Authors:  S Toyabe; A Watanabe; W Harada; T Karasawa; M Uchiyama
Journal:  Immunology       Date:  2001-06       Impact factor: 7.397

3.  Virions released from cells transfected with a molecular clone of human T-cell leukemia virus type I give rise to primary and secondary infections of T cells.

Authors:  D Derse; J Mikovits; M Polianova; B K Felber; F Ruscetti
Journal:  J Virol       Date:  1995-03       Impact factor: 5.103

4.  Time course and cytokine dependence of human T-cell lymphotropic virus type 1 T-lymphocyte transformation as revealed by a microtiter infectivity assay.

Authors:  D Persaud; J L Muñoz; S L Tarsis; E S Parks; W P Parks
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

5.  In vivo cellular tropism of human T-cell leukemia virus type 1.

Authors:  J H Richardson; A J Edwards; J K Cruickshank; P Rudge; A G Dalgleish
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

6.  Production of plasminogen activators by human T-cell leukaemia virus-transformed human T cell lines.

Authors:  S Hinuma; S Honda; K Tsukamoto; K Sugamura; Y Hinuma
Journal:  Br J Cancer       Date:  1985-06       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.